Marc Tarpenning and Martin Eberhard dreamed up Tesla, then convinced Elon Musk to fund it. Two decades later, they’re backing TELO, a maker of pint-sized electric trucks.
Job security is evolving in the age of AI and economic uncertainty. Learn what career stability looks like in 2026 and how to strengthen your future prospects.
AI Startup Corgi Fundraises Yet Again, At $4 Billion Valuation
Thanks to a quirky financial regulation, the Discover deal is already generating significant incremental revenue.
YouTube creator Gossip Goblin brings AI-assisted feature “Gods Don’t Give Gifts” to U.S. theaters, testing whether online fandom can drive box office.
In this week’s edition of InnovationRx, we look at the companies looking to cash in on the coming peptide bonanza, the ongoing cyclosporiasis outbreak, Tempus’s acquisition of a cancer-testing company, and more.
With an FDA panel expected to recommend legal production of as many as seven peptides this week, compounding pharmacies and telehealth companies are preparing for the coming bonanza.
More than 600,000 police reports have been written with help from Axon’s AI tools. Public records obtained by Forbes show that they can introduce errors that cops have to spend time editing out.
Chinese open-source models like Kimi and Deepseek are now dominant AI tools. American startups like Thinking Machines, Reflection AI and now Poolside are trying to challenge that.
Khosla Ventures is putting $30 million into Twenty, a cyber startup that uses AI models from Anthropic and OpenAI to run hacking campaigns for the Department of War.